Infant leukemia, topoisomerase II inhibitors, and the MLL gene

Journal of the National Cancer Institute

Volumn 86, Issue 22, 1994, Pages 1678-1680

  Ross, Julie A ^a   Potter, John D ^b   Robison, Leslie L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ACUTE DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; CHROMOSOME 11; CHROMOSOME ABERRATION; ENZYMOLOGY; GENETICS; HUMAN; IATROGENIC DISEASE; INFANT; LEUKEMIA; MYELOID LEUKEMIA; REVIEW; SECOND CANCER;

ACUTE DISEASE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; DNA TOPOISOMERASES, TYPE II; HUMAN; INFANT; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOID; NEOPLASMS, SECOND PRIMARY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028775357     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.22.1678     Document Type: Article

References (30)

1. Auxenfants E, Morel P, Lai JL, et al: Secondary acute lymphoblastic leukemia with t (4;11). Ann Hematol 65:143-146, 1992.
2. Winick NJ, McKenna RW, Shuster JJ. et al: Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide [see comment citations in Medline]. J Clin Oncol 11:209-217,1993.
3. Michels SD, McKenna RW, Arthur DC, et al: Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 65:1364-1372, 1985.
4. Pui CH, Behm FG, Raimondi SC, et al: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia [see comment citation in Medline], N Engl J Med 321:136-142, 1989.
5. Kumar L: Epipodophyllotoxins and secondary leukaemia. Lancet 342:819-820. 1993.
6. Calabresi P, Chabner BA: Antineoplastic agents. In The Pharmacological Basis of Therapeutics, 8th ed (Gilman AG. Rail TW, Nies AS, et al, eds). New York: Pergamon Press, 1990. pp 1209-1263.
7. Long BH: Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Semin Oncol 19:S3-S19, 1992.
8. Gerwirtz DA: Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? Biochem Pharmacol 42:2253-2258,1991.
9. Negrini M, Felix CA, Martin C, et al: Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9; 11) chromosome translocation in acute myeloid leukemia. Cancer Res 53:4489-4492, 1993.
10. Djabali M, Selleri L, Parry P, et al: A trithorax-like gene is interrupted by chromosome 1 lq23 translocations in acute leukemias. Nat Genet 2:13-18, 1992.
11. Lawrence HJ, Largman C: Homeobox genes in normal hematopoiesis and leukemia Blood 80:2445-2453, 1992.
12. Felix CA, Winick NJ, Negrini M, et al: Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Cancer Res 53:2954-2956,1993.
13. Cimino G, Lo Coco F, Biondi A, et al: ALL-1 gene at chromosome 1 lq23 is consistently altered in acute leukemia of early infancy. Blood 82:544-546, 1993.
14. Hunger SP, Tkachuk DC, Amylon MD, et al: HRX involvement in de novo and secondary leukemias with diverse chromosome 11 q23 abnormalities. Blood 81:3197-3203, 1993.
15. Ford AM, Ridge SA, Cabrera ME, et al: In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363:358-360, 1993.
16. Bader JL, Miller RW: US cancer incidence and mortality in the first year of life. AmJDis Child 133:157-159, 1979.
17. Parkin DM, Stiller CA, Draper GJ, et al, eds: International Incidence of Childhood Cancer, IARC Scientific Publications, No. 87, Lyon, 1988.
18. Robison LL, Neglia JP, Mertens A: Epidemiology and etiology of childhood cancer. In Clinical Pediatric Oncology, 4th ed. St. Louis: Mosby, 1990, pp 11-28.
19. Robison LL, Buckley JD, Daigle AE, et al: Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 63:1904-1911,1989.
20. Severson RK, Buckley JD, Woods WG, et al: Cigarette smoking and alcohol consumption of parents of children with acute myeloid leukemia: an analysis within morphologic subgroups-a report from the Children’s Cancer Study Group. Cancer Epidemiol Biomarkers Prev 2:433-439, 1993.
21. Buckley JD, Robison LL, Swotinsky R, et al: Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Children’s Cancer Study Group. Cancer Res 49:4030-4037, 1989.
22. Yamashita T, Kawada SZ, Nakano H: Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 39: 737-744, 1990.
23. Pommier Y, Bertrand R: The mechanisms of formation of chromosomal aberrations: role of eukaryotic DNA topoisomerases. In The Causes and Consequences of Chromosomal Aberrations (Kirsch IR, ed). Boca Raton, Fla.: CRC Press, Inc., 1993, pp 277-309.
24. Pierpoint WS: Flavonoids in the human diet. In Plant Flavonoids in Biology and Medicine, Biochemical, Pharmacological, and Structure-Activity Relationships (Cody V, Middleton E Jr, Harbome JB, eds). New York: AlanR. Liss, 1986, pp 125-140.
25. Austin CA, Patel S, Ono K, et al: Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 282:883-889, 1992.
26. Epstein RJ: Topoisomerases in human disease. Lancet 1:521-524, 1988.
27. Ling MR: Therapy of genital human papillomavirus infections. Part II: methods of treatment [see comment citation in Medline]. Int J Dermatol 31:769-776, 1992.
28. Ferguson LR, Peason A: Chromosomal changes in Chinese hamster AA8 cells caused by podophyllin, a common treatment for genital warts. Mutat Res 266:231-239,1992.
29. Steinmetz KA, Potter JD: Review: vegetables, fruit and cancer. II. Mechanisms. Cancer Causes Control 2:427-442, 1991.
30. Marshall E: Toxicology goes molecular. Science 259:1394-1398, 1993.